Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3fRrAwe
via IFTTT